CSIMarket
 


Nuvation Bio Inc   (NUVB)
Other Ticker:  
 
 

NUVB's Operating Income Growth by Quarter and Year

Nuvation Bio Inc 's Operating Income results by quarter and year




NUVB Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -24.33 -29.61 0.00
III Quarter September -26.34 -29.34 -22.79 0.00
II Quarter June -26.13 -37.87 -20.43 0.00
I Quarter March -26.52 -28.19 -20.48 0.00
FY   -78.99 -119.73 -93.31 0.00



NUVB Operating Income third quarter 2023 Y/Y Growth Comment
Nuvation Bio Inc in the third quarter 2023 recorded Operating Loss of $ -26.34 millions.

According to the results reported in the third quarter 2023, Nuvation Bio Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Nuvation Bio Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


NUVB Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Nuvation Bio Inc 's third quarter 2023 Operating Income $ -26.34 millions NUVB's Income Statement
Nuvation Bio Inc 's third quarter 2022 Operating Income $ -29.34 millions Quarterly NUVB's Income Statement
New: More NUVB's historic Operating Income Growth >>


NUVB Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nuvation Bio Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NUVB's III. Quarter Q/Q Operating Income Comment
Recent accomplishment of -26.34 millions by Nuvation Bio Inc look even more unfavourable compare to the Operating Loss -26.13 millions a quarter before.

Within Major Pharmaceutical Preparations industry Nuvation Bio Inc achieved highest sequential Operating Income growth. While Nuvation Bio Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NUVB's III. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -26.34 millions by Nuvation Bio Inc come out even worse compare to the -26.13 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Nuvation Bio Inc achieved highest sequential Operating Income growth. While Nuvation Bio Inc 's Operating Income growth quarter on quarter, overall rank is .


Nuvation Bio Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -103.33 $ -106.32 $ -118.06 $ -119.73 $ -125.01
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Nuvation Bio Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Nuvation Bio Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
NUVB's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for NUVB's Competitors
Operating Income Growth for Nuvation Bio Inc 's Suppliers
Operating Income Growth for NUVB's Customers

You may also want to know
NUVB's Annual Growth Rates NUVB's Profitability Ratios NUVB's Asset Turnover Ratio NUVB's Dividend Growth
NUVB's Roe NUVB's Valuation Ratios NUVB's Financial Strength Ratios NUVB's Dividend Payout Ratio
NUVB's Roa NUVB's Inventory Turnover Ratio NUVB's Growth Rates NUVB's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Bio techne Corp-0.81%$ -0.808 millions
The Pennant Group Inc -1.16%$ -1.162 millions
Bio rad Laboratories Inc -1.99%$ -1.990 millions
Corcept Therapeutics Inc-2.37%$ -2.371 millions
Mettler toledo International Inc -3.07%$ -3.068 millions
Tenet Healthcare Corp-4.70%$ -4.698 millions
West Pharmaceutical Services Inc -4.78%$ -4.780 millions
Bruker Corporation-5.18%$ -5.179 millions
Henry Schein Inc-5.21%$ -5.213 millions
Hologic Inc-5.96%$ -5.962 millions
Sonida Senior Living Inc -6.27%$ -6.269 millions
Abbott Laboratories-6.95%$ -6.949 millions
Gilead Sciences Inc -7.54%$ -7.543 millions
Vertex Pharmaceuticals Inc-7.86%$ -7.864 millions
Bristol myers Squibb Company-9.18%$ -9.183 millions
Regeneron Pharmaceuticals Inc -9.21%$ -9.210 millions
National Research Corporation-10.39%$ -10.388 millions
Quest Diagnostics Inc-12.76%$ -12.755 millions
Bausch and Lomb Corp-13.04%$ -13.043 millions
Carlisle Companies Incorporated-13.87%$ -13.871 millions
Pediatrix Medical Group Inc -15.01%$ -15.015 millions
Community Health Systems Inc -15.20%$ -15.196 millions
Teva Pharmaceutical Industries Limited-15.27%$ -15.274 millions
Zynex inc -16.36%$ -16.362 millions
Entera Bio Ltd -16.72%$ -16.719 millions
Pacira Biosciences inc -16.76%$ -16.760 millions
Viatris Inc -19.35%$ -19.354 millions
Royalty Pharma Plc-21.21%$ -21.210 millions
Luna Innovations Inc-22.06%$ -22.057 millions
Avantor Inc -23.79%$ -23.785 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com